Towards a European strategy to address the COVID-19 pandemic (2021)
Attributed to:
Biomedicine and Beyond: The Social and Regulatory Dimensions of Therapeutics in Japan and the UK
funded by
FIC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(21)01808-0
Publication URI: http://dx.doi.org/10.1016/s0140-6736(21)01808-0
Type: Journal Article/Review
Parent Publication: The Lancet
Issue: 10303